Johnson & JohnsonvsSANUWAVE Health

JNJ and SNWV stock compared: price, dividend, valuation and results, from SEC filings.

SNWV

SANUWAVE Health, Inc.

$1.59

Value $14M

+0.59%
SNWV's page

Johnson & Johnson (JNJ) has a market value of $644B and SANUWAVE Health (SNWV) $14M. Over the last year, with dividends, JNJ moved +39.7% and SNWV -94.8%. The P/E is 40.0 for JNJ and 3.3 for SNWV. Dividend yield: JNJ 1.98%, SNWV none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$644B

    SNWV$14M

    JNJ is 47,112 times SNWV

  • Revenue, 12 months

    JNJ$99.3B

    SNWV$41M

    JNJ is 2,403 times SNWV

  • Net income, 12 months

    JNJ$16.1B

    SNWV$4.2M

    JNJ is 3,874 times SNWV

  • Operating margin

    JNJ–

    SNWV-1.1%

  • ROIC

    JNJ12.4%

    SNWV-2.4%

    14.8 points apart

  • P/E

    JNJ40.0

    SNWV3.3

    JNJ is 12 times SNWV

  • Dividend yield

    JNJ2.0%

    SNWV0.0%

    2.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+39.7%

SNWV-94.8%

050100150DecFebAprJunAugOct
Returns by period
PeriodJNJWith dividendsSNWVWith dividends
1 year since November 17, 2025+39.7%Price +36.6%-94.8%Price -94.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonSNWVSANUWAVE Health

Valuation

JNJSNWV
Valuation
Price$267.14$1.59
Market value$644B$14M
Enterprise value (EV)$671B$24M
P/E40.03.3
P/E, 5-year median21.9–
P/B7.94.8
EV/EBIT37.8–
Free cash flow yield3.2%19.0%

Results and growth

JNJSNWV
Results and growth
Revenue, 12 months$99.3B$41M
Net income, 12 months$16.1B$4.2M
Free cash flow, 12 months$20.6B$2.6M
Earnings per share, 12 months$6.59-$0.21
Revenue growth, year on year6.1%35.0%
Revenue growth a year, past+2.7%over 5 years+61.1%over 5 years
EPS growth a year, past+14.9%over 5 years–

Margins and returns on capital

JNJSNWV
Margins and returns on capital
Gross margin67.6%76.2%
Operating margin–-1.1%
Net margin16.2%10.1%
ROIC12.4%-2.4%
ROE19.7%1,383.2%

Balance sheet

JNJSNWV
Balance sheet
Cash$17.2B$6.6M
Total debt$44.7B$18M
Net debt / EBITDA1.120.0
Interest cover18.0×–

Dividends and buybacks

JNJSNWV
Dividends and buybacks
Dividend yield2.0%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%–
Shareholder yield2.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or SNWV

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or SANUWAVE Health?

By market value, Johnson & Johnson ($644B) is about 47,112.3 times SANUWAVE Health ($14M), at today's prices.

How did JNJ and SNWV stock do over the last 1 years?

Since November 17, 2025, JNJ's price moved +36.6% and SNWV's -94.8%. With dividends: JNJ +39.7% (+39.7% a year), SNWV -94.8% (-94.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or SNWV?

The dividend yield at today's price is 1.98% for Johnson & Johnson and none for SANUWAVE Health. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and SNWV?

At today's price, the P/E is 40.0 for JNJ and 3.3 for SNWV. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Johnson & Johnson or SANUWAVE Health?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 10.1% for SANUWAVE Health, and the operating margin – and -1.1%. Revenue was $99.3B and $41M.

Which is the better investment, Johnson & Johnson or SANUWAVE Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.